Discovery Tools (Healthcare) · Waltham, MA · Founded 2013 · Privately Held (backing)
Developer of diagnostics and a precision medicine platform designed for therapy selection and drug development in autoimmune diseases. Scipher Medicine is based in Waltham, MA and was founded in 2013. Its last known valuation is $496 million. It has raised $232 million across 6 recorded rounds; the latest was a $5.8 million early-stage round in May 2024.
Last price · $/share
—
Implied valuation
$495.9M
Total raised
$232.0M
Last round
Early Stage VC
May 2024
No prints on record
No secondary trades in Scipher Medicine shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Scipher Medicine with a free account
·The complete investor list: 18 names
·Watch Scipher Medicine: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Scipher Medicine stock.
